Thoracic Cancer

Papers
(The H4-Index of Thoracic Cancer is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Issue Information195
Issue Information60
Issue Information50
Issue Information42
Issue Information41
Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors35
Multi‐center experience in an optimized right upper lobectomy surgical procedure in China34
A case of eosinophilic bronchiolitis after the initiation of immune checkpoint inhibitor34
Electromagnetic navigational bronchoscopy‐guided dye marking to identify the subsegmental bronchus in thoracoscopic anatomic subsegmentectomy32
Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows30
Thoracic skeletal muscle mass predicts mortality in patients with surgery for pleural empyema: A case control study30
Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report29
PRPS2‐mediated modulation of the antitumor immune response in lung cancer through CCL2‐mediated tumor‐associated macrophages and myeloid‐derived suppressor cells29
Diabetic ketoacidosis shortly after COVID‐19 vaccination in a non–small‐cell lung cancer patient receiving combination of PD‐1 and CTLA‐4 inhibitors: A case report28
Response to ALK‐TKIs in a lung adenocarcinoma patient harboring dual DCTN1‐ALK and ALK‐CLIP4 rearrangements26
Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab26
PET–CT for visualizing the pathophysiology of COPD in patients with early‐stage NSCLC26
Angiosarcoma of breast and chest wall complicated with tuberculous empyema: A case report26
Long‐term follow‐up of unresectable adenoid cystic carcinoma of the trachea and bronchus treated with high‐dose proton beam therapy: A report of two cases25
Secular trends of morbidity and mortality of thyroid cancer in five Asian countries from 1990 to 2019 and their predictions to 203524
Relationship between the severity of emphysematous change in the lung and morbidity after esophagectomy for esophageal cancer: A retrospective study on a novel strategy for risk prediction23
Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC‐MS/MS23
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer23
0.059773921966553